University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

Zegenex Inc.

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Therapeutics

Therapeutic Areas

Dermatology

Founders

Michael TsangManush Saydmohammed

Website

https://zegenex.com/
Zegenex Inc.

Zegenex is developing topical treatments to help persistent wounds heal. Built on University of Pittsburgh research and licensed technology, its small-molecule platform is designed to reactivate the body's tissue-repair processes. The company's lead program focuses on diabetic foot ulcers, with potential applications in other chronic and complex wounds. [1]

Co-founded by Michael Tsang and Manush Saydmohammed, Zegenex brings regenerative biology into practical wound-care development. Its investigational formulations are designed for room-temperature storage and straightforward topical application, with the goal of making advanced wound care easier to deliver. The company is advancing its preclinical program toward human studies. [2] [1]

Discover More with AI